PANANGIN

Medicinal product

(Invented) name

PANANGIN

Active substance (s)

Kalio aspartatas/Magnio aspartatas

Strength

316 mg/280 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A12BA30, potassium (different salts in combination

Marketing authorisation holder

Gedeon Richter Plc, Vengrija

Date of authorisation

2017-07-19

Date of renewal

2022-01-10

Documents

4111 PANANGIN 316mg_280mg RPP 202 07 07.docx

4111 Pakuotės lapelis 2022 07 07.docx

Panangin tab_Gedeon_viesas_AR.doc

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kalio aspartatas	316 mg
Magnio aspartatas	280 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68817	83400	1083400	lizdinė plokštelė	N30		Nereceptinis	LT/1/17/4111/001	Tiekiama	-	-	No	-	-	Download
68818	83401	1083401	lizdinė plokštelė	N60		Nereceptinis	LT/1/17/4111/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-01-10	Perregistruotas
2017-07-19	Registruotas